Melanoma-associated antigen A1 (MAGEA1) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
MAGEA1 Antibody is a Rabbit Polyclonal against MAGEA1.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Melanoma-associated antigen A1 (MAGEA1) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | ELISA: 1/10000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P43355 |
| Gene ID | 4100 |
| Background | Antibody anti-MAGEA1 |
| Status | RUO |
Descripción
Related Products
Human MAGEA1 (Melanoma-associated antigen 1) ELISA Kit
Ver Producto
anti- MAGEA1 antibody
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.
Ver Producto
anti- MAGEA1 antibody
May be involved in transcriptional regulation through interaction with SNW1 and recruiting histone deactelyase HDAC1. May inhibit notch intracellular domain(NICD) transactivation. May play a role in embryonal development and tumor transformation or aspects of tumor progression. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.
Ver Producto